Raghavender Medishetti

532 citations

31 papers · 400 indexed · h-index 13

Co-authors: Pushkar Kulkarni Perumal Yogeeswari Dharmarajan Sriram Manojit Pal Jonnalagadda Padma Sridevi Janupally Renuka Gautham G. Shenoy Kishore V. L. Parsa
Topics: Zebrafish Biomedical Research Applications (5 papers)Synthesis and biological activity (4 papers)Synthesis and Catalytic Reactions (4 papers)
Cited by: Toxicology Organic Chemistry Molecular Medicine
Journals: Developmental Cell European Journal of Medicinal Chemistry Bioorganic & Medicinal Chemistry
Partner nations: India United States Oman

In The Last Decade

Raghavender Medishetti

29 papers receiving 393 citations

Peers

Countries citing papers authored by Raghavender Medishetti

Since Specialization

Citations

This map shows the geographic impact of Raghavender Medishetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raghavender Medishetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raghavender Medishetti more than expected).

Fields of papers citing papers by Raghavender Medishetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raghavender Medishetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raghavender Medishetti. The network helps show where Raghavender Medishetti may publish in the future.

Co-authorship network of co-authors of Raghavender Medishetti

This figure shows the co-authorship network connecting the top 25 collaborators of Raghavender Medishetti. A scholar is included among the top collaborators of Raghavender Medishetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raghavender Medishetti. Raghavender Medishetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Further delineation of defects in MRPS2 causing human OXPHOS deficiency and early developmental abnormalities in zebrafish 2025 ·European Journal of Human Genetics ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Priti S. Hegde,(unknown),Raghavender Medishetti,(unknown),(unknown),(unknown),(unknown),Akhilesh Pandey,(unknown),Sanjiban Chakrabarty,Anju Shukla	0
2	Enhancing topical drug delivery of Apremilast through niosomal gel formulation: Ex vivo skin permeation and in vivo evaluation for psoriasis 2025 ·The Thai Journal of Pharmaceutical Sciences ·(unknown),(unknown),Yogesh Jaiswal,Bantal Veeresh,Raghavender Medishetti	0
3	Biallelic variants in CCN2 underlie an autosomal recessive kyphomelic dysplasia 2024 ·European Journal of Human Genetics ·Swati Singh,Sumita Danda,Neetu Sharma,Hitesh Shah,Vrisha Madhuri,(unknown),(unknown),Raghavender Medishetti,Alka V. Ekbote,Gandham SriLakshmi Bhavani,(unknown),Katta M. Girisha	1
4	EYA protein complex is required for Wntless retrograde trafficking from endosomes to Golgi 2024 ·Developmental Cell ·(unknown),Raghavender Medishetti,(unknown),(unknown),Kavita Babu,Manish Jaiswal,Kiranam Chatti,Subbareddy Maddika	3
5	Design, synthesis and evaluation of 2-aryl quinoline derivatives against 12R-lipoxygenase (12R-LOX): Discovery of first inhibitor of 12R-LOX 2023 ·Bioorganic Chemistry ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Raghavender Medishetti,(unknown),(unknown),Mahaboobkhan Rasool,Sandipan Chakraborty,Nooruddin Khan,Pallu Reddanna,Srinivas Oruganti,Manojit Pal	6
6	Wang resin catalysed sonochemical synthesis of pyrazolo[4,3-d]pyrimidinones and 2,3-dihydroquinazolin-4(1H)-ones: Identification of chorismate mutase inhibitors having effects on Mycobacterium tuberculosis cell viability 2023 ·Bioorganic Chemistry ·(unknown),R. Nishanth Rao,(unknown),(unknown),Jamma Trinath,Raghavender Medishetti,Sharmistha Banerjee,(unknown),Gautham G. Shenoy,Srinivas Oruganti,Parimal Misra,Manojit Pal	13
7	CRISPR-Cas9-induced gene knockout in zebrafish 2022 ·STAR Protocols ·Raghavender Medishetti,(unknown),(unknown),(unknown),(unknown),Anil K. Challa,Kishore V. L. Parsa,Kiranam Chatti	8
8	Fe(III)-catalyzed regioselective and faster synthesis of isocoumarins with 3-oxoalkyl moiety at C-4: Identification of new inhibitors of PDE4 2022 ·Bioorganic Chemistry ·(unknown),(unknown),(unknown),(unknown),J.S. Dileep Kumar,(unknown),(unknown),Raghavender Medishetti,Snigdha Samarpita,Mahaboobkhan Rasool,(unknown),Gautham G. Shenoy,Kishore V. L. Parsa,Manojit Pal	4
9	CuCl2-catalyzed inexpensive, faster and ligand/additive free synthesis of isoquinolin-1(2H)-one derivatives via the coupling–cyclization strategy: Evaluation of a new class of compounds as potential PDE4 inhibitors 2021 ·Bioorganic Chemistry ·(unknown),(unknown),(unknown),J.S. Dileep Kumar,Ravikumar Kapavarapu,Raghavender Medishetti,Jayesh Mudgal,(unknown),Gautham G. Shenoy,C. Mallikarjuna Rao,Kiranam Chatti,Kishore V. L. Parsa,Manojit Pal	13
10	PdCl2-catalyzed synthesis of a new class of isocoumarin derivatives containing aminosulfonyl / aminocarboxamide moiety: First identification of a isocoumarin based PDE4 inhibitor 2021 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),J.S. Dileep Kumar,(unknown),Raghavender Medishetti,Snigdha Samarpita,Mahaboobkhan Rasool,Jayesh Mudgal,(unknown),Gautham G. Shenoy,C. Mallikarjuna Rao,Kiranam Chatti,Kishore V. L. Parsa,Manojit Pal	17
11	InCl3 mediated heteroarylation of indoles and their derivatization via C H activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis 2019 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),(unknown),J.S. Dileep Kumar,(unknown),Raghavender Medishetti,Pushkar Kulkarni,Ravikumar Kapavarapu,Mahaboobkhan Rasool,Jayesh Mudgal,(unknown),Gautham G. Shenoy,Kishore V. L. Parsa,Manojit Pal	34
12	A DNAzyme based knockdown model for Fragile-X syndrome in zebrafish reveals a critical window for therapeutic intervention 2019 ·Journal of Pharmacological and Toxicological Methods ·Raghavender Medishetti,(unknown),(unknown),(unknown),(unknown),Uday Saxena,Pushkar Kulkarni,(unknown)	7
13	Double PEGylation Significantly Improves Pharmacokinetic Properties of Irinotecan Containing Nanoparticles in a Zebrafish Model 2018 ·Uday Saxena,(unknown),(unknown),(unknown),Raghavender Medishetti,(unknown),(unknown)	1
14	Larval zebrafish model for studying the effects of valproic acid on neurodevelopment: An approach towards modeling autism 2018 ·Journal of Pharmacological and Toxicological Methods ·Shubham Dwivedi,Raghavender Medishetti,(unknown),(unknown),Pushkar Kulkarni,Perumal Yogeeswari	41
15	Correlation of pharmacokinetics and brain penetration data of adult zebrafish with higher mammals including humans 2017 ·Journal of Pharmacological and Toxicological Methods ·Pushkar Kulkarni,Raghavender Medishetti,(unknown),(unknown),(unknown),(unknown),Dharmarajan Sriram,Uday Saxena,Srinivas Oruganti,Perumal Yogeeswari	7
16	Novel Zebrafish EAE model: A quick in vivo screen for multiple sclerosis 2016 ·Multiple Sclerosis and Related Disorders ·Pushkar Kulkarni,(unknown),Raghavender Medishetti,Dharmarajan Sriram,Uday Saxena,Perumal Yogeeswari	28
17	Design and synthesis of novel quinoline–aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors 2015 ·Bioorganic & Medicinal Chemistry ·(unknown),Janupally Renuka,Shalini Saxena,Jonnalagadda Padma Sridevi,Raghavender Medishetti,Pushkar Kulkarni,Perumal Yogeeswari,Dharmarajan Sriram	48
18	Ligand-free MCR for linking quinoxaline framework with a benzimidazole nucleus: a new strategy for the identification of novel hybrid molecules as potential inducers of apoptosis 2014 ·Organic & Biomolecular Chemistry ·(unknown),(unknown),(unknown),Raghavender Medishetti,Pushkar Kulkarni,Manojit Pal	19
19	Exploring the gyrase ATPase domain for tailoring newer anti-tubercular drugs: Hit to lead optimization of a novel class of thiazole inhibitors 2014 ·Bioorganic & Medicinal Chemistry ·Variam Ullas Jeankumar,(unknown),Janupally Renuka,Priyanka Suryadevara,Jonnalagadda Padma Sridevi,Raghavender Medishetti,Pushkar Kulkarni,Perumal Yogeeswari,Dharmarajan Sriram	22
20	Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: Scaffold hopping from known antibacterial leads 2013 ·International Journal of Antimicrobial Agents ·Variam Ullas Jeankumar,Janupally Renuka,(unknown),Vijay Soni,Jonnalagadda Padma Sridevi,Priyanka Suryadevara,Shravan Morla,Raghavender Medishetti,Pushkar Kulkarni,Perumal Yogeeswari,Dharmarajan Sriram	32

About Raghavender Medishetti

Raghavender Medishetti is a scholar working on Toxicology, Organic Chemistry and Cancer Research, having authored 31 papers that have together received 400 indexed citations. Recurring topics across this work include Zebrafish Biomedical Research Applications (5 papers), Synthesis and biological activity (4 papers) and Synthesis and Catalytic Reactions (4 papers). The work is most often cited by research in Toxicology (25 citations), Organic Chemistry (169 citations) and Molecular Medicine (20 citations). Raghavender Medishetti has collaborated with scholars based in India, United States and Oman. Frequent co-authors include Pushkar Kulkarni, Perumal Yogeeswari, Dharmarajan Sriram, Manojit Pal, Jonnalagadda Padma Sridevi, Janupally Renuka, Gautham G. Shenoy, Kishore V. L. Parsa, J.S. Dileep Kumar and Uday Saxena. Their work appears in journals such as Developmental Cell, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact